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Background: Visceral obesity is the most powerful contributor to the development of metabolic syndrome (MetS) and cardio-
vascular diseases. In light of visceral obesity, however, there is a paucity of data on the appropriate cutoff point of waist circum-
ference (WC) in subjects with type 2 diabetes. The aim of this study was to investigate the optimal cutoff value for WC that sig-
nals insulin resistance (IR) and visceral obesity in Koreans with type 2 diabetes.
Methods: We evaluated 4,252 patients with type 2 diabetes (male 2,220, female 2,032, mean age 57.24 years) who visited our 
clinic between January 2003 and June 2009. WC was measured at the midpoint between the lower rib and the iliac crest, and in-
sulin sensitivity was assessed by the rate constant of plasma glucose disappearance (Kitt %/min) using an insulin tolerance test. 
Visceral fat thickness was measured using ultrasonography. Statistical analysis was performed using receiver operating charac-
teristic curve. 
Results: The optimal cutoff points for WC for identifying the presence of IR and visceral obesity, as well as two or more metabol-
ic components, were 87 cm for men and 81 cm for women. Moreover, these cutoff points had the highest predictive powers for 
the presence of visceral obesity. The MetS defined by new criteria correlated with the increased carotid intima-media thickness 
in female subjects.
Conclusion: Our results suggest that the optimal cutoff values for WC in Koreans with type 2 diabetes should be reestablished 
based on IR and visceral obesity.
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INTRODUCTION
The prevalence of type 2 diabetes mellitus (T2DM) and meta-
bolic syndrome (MetS) is increasing worldwide, especially in 
developing countries, in conjunction with increasing obesity 
and westernized lifestyles, and both of them have become major 
public health concerns [1,2]. People with MetS are at 2 and 5 
times higher risk, respectively, of developing cardiovascular dis-
ease (CVD) and T2DM [3]. One study reported that as many as 
86% of patients with diabetes aged 50 years and older had MetS 
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[4], indicating that these two conditions have a close relation-
ship. Although the pathogenesis of MetS has not fully been elu-
cidated, insulin resistance (IR) and central obesity are thought 
to be two main factors [5]. Visceral obesity is highly correlated 
with IR [5,6], and visceral fat tissue has been demonstrated to 
be an important source of free fatty acids and inflammatory cy-
tokines [7], thereby contributing to the development of CVDs 
[8]. Therefore, it is important for clinicians to detect the pres-
ence of IR and visceral obesity in managing patients with type 2 
diabetes.
 Waist circumference (WC), which has been found to be a 
better predictor of diabetes than body mass index (BMI) [9], is 
now regarded as a reliable indicator of central obesity [10], even 
though there is still debate regarding whether WC can accurate-
ly reflect the amount of abdominal visceral fat [11]. However, it 
is difficult to determine optimal WC cutoff values as they may 
be affected by sex, race, or ethnicity [10]. The National Choles-
terol Education Program Adult Treatment Panel III (NCEP-
ATP III) suggested 102 cm for men and 88 cm for women as the 
WC cutoff values for diagnosing MetS, but this cutoff point, 
which is based on Western populations, is not appropriate for 
Asians [12]. Asians are more susceptible to obesity-related co-
morbidities than Caucasians, even when they have smaller WCs 
or lower BMI values [13,14]. 
 Provisionally, the International Diabetes Federation (IDF) 
recommended WC cutoff values of 90 and 80 cm for Asian men 
and women, respectively, as thresholds for diagnosing MetS 
[12]; however, several problems still remain. First, due to the di-
versity of ethnic groups in Asia, the appropriate WC cutoff val-
ues differ even among Asian countries: 85 and 90 cm in Japan 
[15], 85 and 80 cm in China [16], and 90 and 85 cm in Korea 
[14], for men and women, respectively. Second, by the current 
criteria for diagnosing MetS, including NCEP-ATP III and IDF, 
most subjects with T2DM are classified as having MetS [2]. 
Third, Korean patients with diabetes typically show different 
clinical patterns compared with Westerners; nonobese type, 
which is defined as a BMI of less than 25 kg/m2, is more com-
mon (70% to 80%) [17], and a defect in insulin secretion might 
be a major cause of type 2 diabetes in Koreans [18]. However, 
both the NCEP-ATP III and IDF criteria, which are commonly 
used worldwide, do not include a factor that measures IR di-
rectly. Taken together, these factors indicate that the WC cutoff 
points proposed by these criteria are not useful in detecting cen-
tral obesity in Koreans with T2DM. Therefore, ethnic group-
specific WC cutoff values applicable only to type 2 diabetes may 
be required to more accurately predict cardiovascular risk.
 The aim of the current study was to investigate the optimal 
WC cutoff points based on IR and visceral adiposity in Korean 
type 2 diabetes, thereby enabling physicians to easily and ef-
fectively predict each individual’s cardiovascular risk. 
METHODS
Nine thousand five hundred thirty-two patients with diabetes 
were consecutively registered at Huh’s Diabetes Center in Seoul, 
Korea. Among these patients, we enrolled 4,252 subjects with 
type 2 diabetes (2,220 men and 2,032 women, mean age 57.24± 
10.27 years) who visited the clinic from January 2003 to June 
2009. The inclusion criteria were as follows: subjects whose fast-
ing C-peptide levels ≥0.37 nmol/L (or 1.1 ng/mL) and who had 
no anti-glutamic acid decarboxylase antibody; who underwent 
both a short insulin tolerance test (SITT) and abdominal ultra-
sonography. Especially, subjects who were taking thiazolidine-
dione or steroid preparations and those with renal insufficiency 
(serum creatinine ≥1.5 mg/dL) were excluded because the de-
gree of visceral obesity, body weight, or fasting C-peptide levels 
can be greatly affected by these factors. The protocol was ap-
proved by the Ethics Committee of the Yonsei University Col-
lege of Medicine, and all participants signed consent forms. All 
investigations were performed in accordance with the princi-
ples of the Declaration of Helsinki.
 Body weight and height were measured in all subjects while 
they were wearing light clothing and standing barefoot, and 
BMI was calculated by dividing weight (kg) by the square of 
height (m2). WC was measured at the midpoint between the 
lower ribs and the iliac crest at the end of normal expiration. 
All of the participants underwent measurement of fasting plas-
ma glucose, C-peptide, glycosylated hemoglobin (HbA1c), and 
lipid profiles such as triglycerides and total cholesterol levels, 
and completed a questionnaire related to cardiovascular and 
other diseases, as well as smoking and drinking status.
 To identify metabolic components other than WC and fast-
ing blood glucose, we used three NCEP-ATP III criteria [12]: 
(1) blood pressure ≥130/85 mm Hg or the use of antihyperten-
sive medications; (2) triglycerides ≥1.69 mmol/L (or 150 mg/
dL) or speciﬁc treatment for lipid abnormality; and (3) high 
density lipoprotein cholesterol (HDL-C) <1.04 mmol/L (40 
mg/dL) in men or <1.29 mmol/L (50 mg/dL) in women. Since 
all patients had T2DM, they met the criteria for hyperglycemia; 
hence, we defined MetS as those who met two or more criteria 
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among the three listed above. Antihypertensive medications 
included angiotensin-converting enzyme inhibitor, angiotensin 
receptor blocker, calcium channel blocker, and β-blocker. And 
lipid-lowering agents were statin and fenoﬁbrate.
Assessment of insulin sensitivity 
Insulin sensitivity was directly assessed by SITT as the rate con-
stant of plasma glucose disappearance (Kitt %/min) [19-21]. 
The SITT was performed at 0800 h after overnight fasting. Two 
intravenous cannulas, one for blood sampling and the other for 
insulin injection, were established. After 15 minutes of rest, ve-
nous blood samples were collected at 0, 3, 6, 9, 12, and 15 min-
utes after an intravenous bolus injection of prediluted regular 
insulin (Humulin R; Eli Lilly, Indianapolis, IN, USA) at a dose 
of 0.1 U/kg. Plasma glucose concentrations were immediately 
determined after sampling using a Beckman Glucose Analyzer 
II (Beckman Instruments, Fullerton, CA, USA), and the Kitt 
was calculated from the slope of the fall in log-transformed 
plasma glucose values between 3 and 15 minutes [19]. Immedi-
ately after the test, we routinely administered 100 mL of 20% 
dextrose solution intravenously to avoid any potential hypogly-
cemia. The Kitt level was used as an index of insulin sensitivity. 
The subjects were classified by Kitt tertile, with the low tertile 
defined as the IR group.
Assessment of visceral fat thickness and carotid intima-
media thickness 
Visceral fat thickness (VFT) was measured using a high reso-
lution ultrasonographic system with a 3.5 MHz convex probe 
(OGIQ 7; GE, Milwaukee, WI, USA), and was defined as the 
distance between the anterior wall of the aorta and the internal 
face of the rectoabdominal muscle perpendicular to the aorta. 
According to our previous study [22], VFT measured by ultra-
sonography could be a predictor of the presence of MetS or 
CVD in both sexes. Moreover, a VFT of greater than 47.6 and 
35.5 mm in men and women for discriminating the presence 
of MetS showed sensitivity of 71% and 69% and specificity of 
74% and 78% in the men and women, respectively. Therefore, 
in this study, the presence of visceral obesity was defined as a 
VFT of greater than 47.6 and 35.5 mm in men and women, re-
spectively. We also measured bilateral carotid intima-media 
thickness (CIMT) using a high-resolution ultrasonographic 
system (LOGIQ 7; GE) with a 10 MHz linear transducer. The 
CIMT was measured at three points on the far wall of the mid 
and distal common carotid artery, 1 cm proximal to the dilata-
tion of the carotid bulb, and the mean value of six measure-
ments from the right and left common carotid arteries was 
used [23]. The CIMT was deﬁned as the distance between the 
lumen-intima interface and the media-adventitia interface. 
Mean CIMTs, which were the mean levels of the right and left 
IMTs, were used in this study. 
Statistical analysis 
Statistical analyses were conducted using PASW version 18.0 
(SPSS Inc., Chicago, IL, USA) and SAS version 9.2 (SAS Insti-
tute Inc., Cary, NC, USA). Continuous variables were reported 
as mean±standard deviation, and categorical variables were re-
ported as percentages. To compare differences between groups, 
a Student t-test was performed. In addition, receiver operating 
characteristic (ROC) curve analyses were performed to deter-
mine the optimal WC cutoff points for identifying MetS, IR, 
and visceral obesity. The chi-square test was also used to com-
pare the prevalence of metabolic components according to two 
different criteria. P<0.05 was considered statistically signiﬁcant.
RESULTS
The baseline characteristics of subjects are presented in Table 1. 
The average age was 55.47±10.80 years in men and 59.17±9.27 
years in women. The mean duration of T2DM was 7.22±6.89 
years. The mean WC was 87.26 cm in men and 81.69 cm in 
women. Among the 4,252 Korean diabetic subjects, men 
(35.9%) had a WC of greater than 90 cm and women (34.8%) 
had a WC of greater than 85 cm. Subjects in the low tertile of 
insulin sensitivity (Kitt) were older and had a longer duration 
of diabetes than those in the high tertile. In both sexes, there 
were no differences in BMI across the tertiles; however, WC 
and VFT were significantly higher in the low tertile group than 
in the high tertile group. More importantly, the low tertile 
group had a greater CIMT than the high tertile group. In addi-
tion, clear differences in C-peptide, fasting glucose, HbA1c lev-
els, and lipid profiles were found between the low and high ter-
tile groups. The prevalence of MetS components increased sig-
nificantly as IR progressed: two or more metabolic risk factors 
were present in 56.7% and 71.1% of the men and women in the 
low tertile group, respectively (Supplementary Table 1).
Optimal WC cutoff values based on IR and visceral obesity 
in type 2 diabetic patients 
As shown in Table 2, we investigated the sensitivity and specific-
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ity of WC for identifying two or more metabolic risk factors, as 
well as the presence of IR and visceral obesity. In consideration 
of the screening role of WC measurements, the cutoff points to 
attain the highest sensitivity with a specificity of more than 50% 
were finally selected. The optimal cutoff values of WC were 87 
cm for men and 81 cm for women, which were found to be the 
discriminating cutoff for MetS (sensitivity of 61.0% and 60.7% 
and specificity of 55.9% and 55.5% in men and women, respec-
tively), visceral obesity (sensitivity of 73.0% and 70.3% and 
specificity of 70.5% and 71.4% in men and women, respective-
ly), and the low tertile of Kitt (sensitivity of 62.1% and 66.1% 
and specificity of 52.7% and 51.0% in men and women, respec-
tively). We further evaluated the appropriate WC cutoff values 
that could detect patients who had both hypertriglyceridemia 
and visceral obesity, and similar results were obtained; the AUCs 
were 0.723 (95% confidence interval [CI], 0.701 to 0.745) for 
men and 0.694 (95% CI, 0.671 to 0.717) for women. Our criteria 
were also more effective in identifying subjects who had IR than 
Table 1. Baseline characteristics
Characteristic Total (n=4,252) Men (n=2,220) Women (n=2,032)
Age, yr 57.24±10.27 55.47±10.80 59.17±9.27
DM duration, yr 7.22±6.89 7.04±7.04 7.43±6.71
Body mass index, kg/m2 24.69±3.39 24.61±3.24 24.77±3.55
Waist circumference, cm 84.60±8.14 87.26±7.38 81.69±7.95
Systolic blood pressure, mm Hg 136.04±17.93 134.39±17.22 137.86±18.51
Diastolic blood pressure, mm Hg 86.91±11.24 88.24±11.31 85.44±10.97
Kitt, %/min 1.96±0.92 1.95±0.91 1.98±0.93
Fasting glucose, mg/dL 157.81±56.79 159.44±56.72 156.02±56.83
C-peptide, ng/mL 2.11±0.85 2.14±0.84 2.08±0.87
Glycosylated hemoglobin, % 8.28±1.83 8.30±1.90 8.26±1.74
Total cholesterol, mg/dL 197.07±40.94 192.34±40.35 202.25±40.95
Triglyceride, mg/dL 161.84±115.30 166.17±126.98 157.11±100.82
HDL-C, mg/dL 48.94±12.74 46.90±12.14 51.19±13.00
LDL-C, mg/dL 115.55±34.15 112.60±32.77 118.79±35.34
Visceral fat thickness, mm 46.14±17.54 49.75±17.35 42.19±16.88
CIMT, mm 0.833±0.182 0.847±0.185 0.818±0.179
Medications for dyslipidemia, % 698 (16.4) 314 (14.1) 384 (18.9)
Medications for hypertension, % 1,207 (28.4) 562 (25.3) 645 (31.7)
Antidiabetic treatment, %
   Insulin 450 (10.6) 193 (8.7) 257 (12.6)
   Oral medicationsa 2,497 (58.7) 1,234 (55.6) 1,263 (62.2)
   Only diet and exercise 1,305 (30.7) 793 (35.7) 512 (25.2)
MetS components, %b
   Hypertriglyceridemia 2,127 (50.0) 1,059 (47.7) 1,068 (52.6)
   Low HDL-C 1,600 (37.6) 589 (26.7) 1,011 (50.4)
   Hypertension 3,147 (75.0) 1,643 (74.9) 1,504 (75.0)
   More than 2 factors 2,288 (54.6) 1,068 (48.7) 1,220 (61.1)
Values are presented as mean±standard deviation or number (%). 
DM, diabetes mellitus; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; CIMT, carotid intima-media 
thickness; MetS, metabolic syndrome. 
aOral medications included sulfonylurea, metformin, and α-glucosidase inhibitor, bTriglyceride ≥150 mg/dL or medication; low HDL-C, <40 
mg/dL for men and <50 mg/dL for women; blood pressure ≥130/85 mm Hg or antihypertensive medication.
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those who were insulin-sensitive (data not shown).
Differences between the KOSSO criteria and our criteria in 
predicting metabolic risk factors 
Fig. 1 shows differences in the sensitivity and specificity between 
our criteria and previous criteria, suggested by the Korean Soci-
ety for the Study of Obesity (KOSSO) (90 cm for men and 85 cm 
for women). Our cutoff points had a higher sensitivity for iden-
tifying IR and visceral obesity, as well as the presence of MetS. In 
addition, as shown in Table 3, both insulin sensitivity and vis-
ceral adiposity were significantly different between subjects with 
MetS and those without MetS, defined by the two criteria. How-
ever, definite difference was found in CIMT between women 
with MetS and those without MetS only when our criteria were 
used. We further evaluated differences in these metabolic pa-
rameters according to the presence of obesity, which was de-
fined as a BMI of more than 25 kg/m2. Although Kitt level and 
VFT in both obese and nonobese subjects showed similar pat-
tern to those in overall subjects, there was significant difference 
in CIMT between nonobese women with MetS and those with-
out MetS defined only by our criteria (P value 0.014, data not 
shown). Fig. 2 shows the prevalence of metabolic components, 
including hypertriglyceridemia, low HDL-C, and hypertension 
in MetS as defined by the KOSSO criteria and our criteria. In 
both sexes, the number of subjects with each metabolic risk fac-
tor increased significantly when our criteria were applied com-
pared to the KOSSO criteria. 
DISCUSSION
Obesity and MetS are now common in Asia, and Korea is no 
exception [24]. According to data from the 2007 to 2008 Korea 
National Health and Nutrition Examination Surveys, which 
included more than 7,000 participants aged 19 to 65 years, the 
Table 2. Cutoff values for waist circumference to identify subjects with two or more metabolic components, visceral obesity, and 
insulin resistance
Variable
Two or more metabolic risk factorsa Presence of visceral obesityb Presence of IRc
Sensitivity, % Specificity, % Sensitivity, % Specificity, % Sensitivity, % Specificity, %
Men
   85 74.1 43.9 83.6 56.0 74.3 40.2
   86 67.7 50.1 77.9 62.8 68.8 46.8
   87 61.0 55.9 73.0 70.5 62.1 52.7
   88 55.5 61.0 67.6 75.5 57.5 58.4
   89 49.3 66.1 60.5 79.8 51.2 63.8
   90 43.4 71.3 54.2 84.4 45.7 69.2
   95 18.5 88.7 24.5 95.9 21.9 88.9
   AUC (95% CI) 0.616 (0.590−0.641) 0.777 (0.756−0.798) 0.610 (0.584−0.636)
Women
   80 66.0 49.5 76.0 66.0 70.9 45.0
   81 60.7 55.5 70.3 71.4 66.1 51.0
   82 55.8 58.8 65.6 74.7 61.1 54.8
   83 49.7 63.8 59.7 80.0 55.3 60.4
   84 44.6 68.5 53.9 83.9 50.8 65.7
   85 39.6 73.6 47.6 86.9 45.1 70.5
   90 18.3 90.0 21.5 95.2 21.8 88.1
   AUC (95% CI) 0.611 (0.584−0.638) 0.778 (0.756−0.800) 0.603 (0.575−0.632)
IR, insulin resistance; AUC, area under the curve; CI, confidence interval.
aHypertriglyceridemia, triglycerides ≥150 mg/dL or taking medication; low high density lipoprotein cholesterol, <40 mg/dL for men and <50 
mg/dL for women; hypertension, blood pressure≥130/85 mm Hg or taking antihypertensive medication, bThe presence of visceral obesity was 
defined as a visceral fat thickness of greater than 47.6 and 35.5 mm in men and women, respectively, cIR was defined as the low tertile of insulin 
sensitivity. 
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prevalence of MetS is 15.8% in men and 11.6% in women [25]. 
Another study reported that MetS accounts for 77.9% of type 
2 diabetes cases in Korea [26]. Diabetic patients with MetS 
have a higher prevalence of coronary heart disease than those 
without MetS [4]. Type 2 diabetes and MetS are closely con-
nected in terms of IR, which has been thought to play a central 
role in the development of MetS [5]. IR is also associated with 
obesity [27], but not all obese people exhibit features of IR. 
Table 3. Differences in insulin sensitivity (Kitt), VFT, and CIMT according to the presence of metabolic syndrome defined by 
KOSSO criteria and our criteria in subjects with type 2 diabetes
Variable
KOSSO criteria Our criteria
MetS No MetS P value MetS No MetS P value
Men, n 463 1,746 652 1,554
   Kitt, %/min 1.63±0.74 2.04±0.94 <0.001 1.68±0.78 2.07±0.94 <0.001
   VFT, mm 63.49±16.73 46.13±15.56 <0.001 60.23±16.86 45.36±15.54 <0.001
   CIMT, mm 0.851±0.189 0.846±0.184 0.666 0.849±0.188 0.846±0.184 0.729
Women, n 483 1,530 740 1,265
   Kitt, %/min 1.66±0.79 2.07±0.95 <0.001 1.70±0.80 2.13±0.96 <0.001
   VFT, mm 54.97±17.43 38.15±14.52 <0.001 50.91±16.96 37.08±14.62 <0.001
   CIMT, mm 0.828±0.182 0.817±0.177 0.244 0.834±0.184 0.811±0.174 0.007
Values are presented as mean±standard deviation. 
KOSSO, Korean Society for the Study of Obesity; MetS, metabolic syndrome; VFT, visceral fat thickness; CIMT, carotid intima-media thickness.
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Fig. 1. Receiver operating characteristic analysis of waist circumference (WC) to detect the presence of two or more metabolic 
components, visceral obesity, and insulin resistance (IR) in (A) men and (B) women with type 2 diabetes. The higher the area 
under the curve, the greater the predictive power. A WC of 87 cm for men (black circles) and 81 cm for women (black triangles) 
was chosen as the discriminating value to predict two or more metabolic components, and the presence of visceral obesity and 
IR. These cutoff points had the highest predictive powers for the presence of visceral obesity. Moreover, they had higher sensitiv-
ity and specificity compared to the previous criteria—90 cm for men (black squares) and 85 cm for women (black diamonds)—
proposed by the Korean Society for the Study of Obesity. Visceral obesity was defined as a visceral fat thickness of greater than 
47.6 mm for men and 35.5 mm for women, and IR was defined as the low tertile of insulin sensitivity.
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Some investigators have demonstrated metabolic disturbances 
in metabolically obese normal-weight (MONW) [28] or meta-
bolically healthy obese (MHO) individuals [29]; the MONW-
like phenotype showed an increased risk for incident diabetes 
or CVD, whereas the MHO-like phenotype did not confer a 
markedly increased risk [30]. This suggests that IR and body 
fat distribution in each individual play key roles in determin-
ing risk in regards to MetS. However, neither the NCEP-ATP 
III nor IDF criteria include factors that directly reflect IR [12]. 
Instead, central obesity, as assessed by WC cutoff values, has 
been a criterion for diagnosing MetS. 
 According to our previous study [31], mean Kitt value was 
2.03±0.96 in Korean T2DM patients. Moreover, when classiﬁed 
according to insulin sensitivity, patients with no IR had HbA1c 
of 7.7%±1.4%, while HbA1c of patients with IR was 8.5%± 
1.9% (P<0.001) [31]. As expected, VFT and CIMT in the for-
mer group were significantly higher than in the latter group. In 
the current study, the clinical features of the insulin-resistant 
group (low tertile of Kitt) were also very different from those of 
the insulin-sensitive group (high tertile of Kitt). Visceral adi-
pose tissue is generally thought to have a detrimental effect on 
insulin sensitivity and beta cell dysfunction [32]. Furthermore, 
interestingly, clear differences in WC were also found according 
to insulin sensitivity, while BMI was not different among the 
groups. This finding indicates that WC measurement may be 
useful in predicting IR in individuals with type 2 diabetes, even 
though the best adiposity markers for assessing cardiovascular 
risk are still a matter of controversy [23].
 There is ongoing debate over the optimal WC cutoff points 
for identifying metabolic components. Especially, Asians are 
more prone to sarcopenia, which is characterized by low skele-
tal muscle mass and abdominal obesity, with increased IR, com-
pared to Western subjects [24]. Because of ethnic differences, 
the IDF proposed Asian-specific WC cutoff values for central 
obesity based on World Health Organization recommendations 
[2,33]; however, these were mainly targeted at South Asians and 
Chinese [14], not Koreans. In 2007, the KOSSO recommended 
that, in the general population, appropriate WC cutoff points 
for detecting central obesity were 90 cm for men and 85 cm for 
women [14]. Besides, there have been several studies on the op-
timal WC cutoff points for identifying MetS in Koreans, and 
values of 83 to 89 cm in men and 76 to 82 cm in women have 
been proposed [11,34,35]. All of these studies, however, includ-
ed a general population, without regard for type 2 diabetes sta-
tus. There is still a paucity of data on the appropriate cutoff val-
ues for WC for diabetic patients. 
 We propose optimal WC cutoff points for predicting the 
presence of IR and visceral obesity, as well as MetS, of 87 cm 
for men and 81 cm for women. The WC cutoff values in the 
present study are lower than the KOSSO criteria, but a gap be-
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Fig. 2. Differences in the prevalence of metabolic components according to Korean Society for the Study of Obesity (KOSSO) 
criteria and our criteria in (A) men and (B) women with type 2 diabetes. Compared to metabolic syndrome (MetS) as defined by 
the KOSSO criteria, the prevalence of each metabolic component, including hypertriglyceridemia (hyper-TG), low high density 
lipoprotein (HDL) cholesterol, and hypertension (HTN), was significantly greater in both sexes when our criteria were used to 
define MetS.
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tween the points for men and women is similar [14]. Our find-
ings demonstrate that, based on the KOSSO criteria, the sensi-
tivities for diagnosing MetS considerably declined to less than 
40% in women with type 2 diabetes. As a result, only 35.9% of 
diabetic men and 34.8% of diabetic women were classified into 
the group with central obesity. On the other hand, the preva-
lence of central obesity in type 2 diabetes was 52.3% in men 
and 54.8% in women, according to our criteria. Considering 
the actual prevalence, the KOSSO criteria for central obesity 
may be inappropriate for patients with T2DM. One previous 
study reported that the most common MetS pattern in Korea 
was a combination of central obesity, low HDL-C, and hyper-
triglyceridemia [25]. Our criteria were especially useful in pre-
dicting both visceral obesity and hypertriglyceridemia (AUC, 
0.723 for men and 0.694 for women); however, the predictive 
power for low HDL-C was lower than that of other compo-
nents. Moreover as well as the KOSSO criteria, our criteria can 
predict IR and visceral adiposity in subjects with T2DM. It is 
noteworthy that definite differences were observed in CIMT 
between women with MetS and those without MetS when our 
criteria were used, but not the KOSSO criteria.
 The major strength of this study is that we analyzed data ob-
tained from a large data of patients with type 2 diabetes at a sin-
gle institute, and that all the data were collected by a single 
trained study staff. To our knowledge, this is the first observa-
tional study to investigate optimal WC cutoff values based on 
both IR and visceral adiposity, focusing on Koreans with type 2 
diabetes. In addition, SITT was performed in all subjects to as-
sess in vivo insulin sensitivity. SITT has been known to be high-
ly correlated with the insulin sensitivity parameters of the eug-
lycemic hyperinsulinemic clamp technique [19-21]. Moreover, 
according to our previous study, Kitt as derived from SITT can 
be used as a marker of IR and carotid atherosclerosis (subclini-
cal CVD) in subjects with T2DM [36]. Secondly, VFT as mea-
sured by ultrasonography is a reliable index for detecting dia-
betic patients who are at high risk for CVDs [22]. Measurement 
of visceral fat by computed tomography can be accurate, but it 
is difficult for routine use in screening individuals in clinics due 
to several problems, such as radiation exposure, cost-effective-
ness, and availability [37]. Our results demonstrate the useful-
ness of WC measurement as a screening tool in the manage-
ment of type 2 diabetes. WC measurement can be easily used, 
even in an outpatient setting. This study also has some limita-
tions. First, this is a cross-sectionally designed, retrospective 
study. Thus, while our findings reflect an association between 
WC and MetS, IR, or visceral obesity, casual inferences are in-
appropriate. Second, even though CIMT was measured, our 
criteria have limited value in terms of confirmation of cardio-
vascular risk in subjects with diabetes because we did not exam-
ine the relationship between WC values and cardiovascular or 
all-cause mortalities in those who had T2DM. Third, we could 
not completely rule out the confounding effects of various 
medications, such as insulin, metformin, and lipid-lowering 
agents which may influence fasting glucose and C-peptide lev-
els, or the degree of IR and visceral obesity. Fourth, the low ter-
tile of Kitt is not an absolute definition for IR in Korean T2DM. 
Fifth, the ROC curve analyses can be influenced by various 
backgrounds according to the study population [38]. Therefore, 
the results obtained from ROC curves should be interpreted 
carefully. Finally, the WC cutoff points in this study did not 
consider the age of the subjects. A recent study reported that el-
derly Korean men and women showed similar cutoff points for 
identifying MetS [39]. Thus, further studies on age-specific WC 
cutoff values applicable to subjects with T2DM are required.
 In summary, our findings suggest that the optimal cutoff val-
ues for WC in Koreans with type 2 diabetes should be re-estab-
lished based on IR and visceral obesity. The current KOSSO 
criteria for WC for detecting central obesity in the general pop-
ulation may be high for both diabetic men and women; the ap-
propriate WC cutoff points for identifying the presence of IR 
and visceral obesity, as well as two or more metabolic compo-
nents, were 87 cm for men and 81 cm for women. Given the 
importance of individualized therapy for patients with type 2 
diabetes [1], our findings may be very helpful and informative 
for physicians and public healthcare officials. 
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Supplementary Table 1. Baseline characteristics according to insulin sensitivity (kitt%)
Characteristic
Men Women 
Low tertile Middle tertile High tertile P value Low tertile Middle tertile High tertile P value
Age, yr 56.84±11.72 56.76±10.99 55.01±10.54a,b <0.001 60.22±9.92 60.30±9.31 58.67±9.54a,b <0.001
DM duration, yr 8.39±7.63 7.36±7.05a 6.38±6.62a,b <0.001 9.02±6.76 7.57±6.70a 6.48±6.42a,b <0.001
Body mass index, kg/m2 24.69±3.35 24.54±3.35 24.34±3.16 0.071 24.58±3.28 24.63±3.26 24.76±3.59 0.52
Waist circumference, cm 89.25±7.85 87.59±7.17a 85.05±7.12a,b <0.001 83.64±8.15 81.87±7.50a 79.48±8.10a,b <0.001
Kitt, %/min 1.04±0.29 1.86±0.23a 3.08±0.64a,b <0.001 1.06±0.29 1.86±0.22a 3.04±0.68a,b <0.001
Fasting glucose, mg/dL 184.82±65.57 153.65±50.30a 137.87±41.19a,b <0.001 184.28±64.10 149.74±50.52a 134.65±43.01a,b <0.001
C-peptide, ng/mL 2.35±0.92 2.08±0.73a 1.88±0.75a,b <0.001 2.29±0.98 2.03±0.78a 1.77±0.67a,b <0.001
HbA1c, % 9.07±2.02 8.17±1.74a 7.75±1.70a,b <0.001 9.10±1.83 8.20±1.69a 7.63±1.45a,b <0.001
Total cholesterol, mg/dL 198.39±44.22 193.35±37.21a 186.56±37.91a,b <0.001 209.65±44.00 204.43±40.82a 199.37±39.44a,b <0.001
Triglyceride, mg/dL 189.50±143.78 161.09±109.20a 134.80±83.53a,b <0.001 184.68±119.44 155.30±93.79a 128.25±77.02a,b <0.001
HDL-C, mg/dL 46.42±12.25 46.75±11.72 48.27±12.17a,b 0.001 49.39±12.16 51.34±13.24a 52.32±13.07a <0.001
LDL-C, mg/dL 115.53±36.53 113.63±31.09 109.77±31.34a 0.001 122.74±36.71 120.26±35.54 118.92±33.72 0.09
VFT, mm 54.36±18.66 50.50±17.19a 45.25±16.13a,b <0.001 46.81±17.86 43.05±16.46a 37.24±15.39a,b <0.001
CIMT, mm 0.857±0.205 0.850±0.186 0.823±0.184a,b <0.001 0.824±0.185 0.807±0.171 0.794±0.178a 0.001
MetS componentsc
   Hypertriglyceridemia 641 (57.4) 560 (50.0) 408 (36.7) <0.001 670 (64.4) 540 (51.9) 404 (38.9) <0.001
   Low HDL-C 306 (27.6) 279 (25.1) 238 (21.6) 0.004 568 (55.0) 530 (51.6) 478 (47.0) 0.001
   Hypertension 871 (79.4) 836 (75.5) 760 (69.7) <0.001 801 (77.7) 770 (75.8) 711 (70.1) <0.001
   More than 2 factors 623 (56.7) 539 (48.8) 414 (37.8) <0.001 730 (71.1) 639 (62.8) 510 (50.7) <0.001
Values are presented as mean±standard deviation or number (%).
DM, diabetes mellitus; HbA1c, glycosylated hemoglobin; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein choles-
terol; VFT, visceral fat thickness; CIMT, carotid intima-media thickness; MetS, metabolic syndrome. 
aP<0.05 vs. low tertile, bP<0.05 vs. middle tertile, cHypertriglyceridemia, triglycerides ≥150 mg/dL or taking medication; low HDL-C, <40 
mg/dL for men and <50 mg/dL for women; hypertension, blood pressure ≥130/85 mm Hg or taking antihypertensive medication.
